VWM
AZN icon

Venturi Wealth Management’s AstraZeneca AZN Stock Holding History

Venturi Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.69M Sell
14,174
-576
-4% -$108K 0.1% 102
2026
Q1 		$2.91M Buy
14,750
+551
+4% +$106K 0.13% 92
2025
Q4 		$2.61M Buy
14,199
+1,241
+10% +$218K 0.12% 96
2025
Q3 		$1.99M Sell
12,958
-7
-0.1% -$1.06K 0.09% 117
2025
Q2 		$1.81M Buy
12,965
+245
+2% +$34.3K 0.09% 131
2025
Q1 		$1.87M Buy
12,720
+522
+4% +$75.5K 0.1% 125
2024
Q4 		$1.6M Sell
12,198
-700
-5% -$98K 0.08% 149
2024
Q3 		$2.01M Buy
12,898
+1,484
+13% +$240K 0.11% 112
2024
Q2 		$1.78M Buy
11,414
+1,385
+14% +$208K 0.11% 117
2024
Q1 		$1.36M Sell
10,029
-1,650
-14% -$218K 0.09% 142
2023
Q4 		$1.57M Sell
11,679
-379
-3% -$49.3K 0.11% 110
2023
Q3 		$1.63M Buy
12,058
+26
+0.2% +$3.55K 0.13% 96
2023
Q2 		$1.72M Sell
12,032
-1,169
-9% -$172K 0.14% 85
2023
Q1 		$1.83M Buy
13,201
+1,410
+12% +$190K 0.15% 91
2022
Q4 		$1.6M Buy
11,791
+104
+0.9% +$13K 0.14% 102
2022
Q3 		$1.28M Sell
11,687
-385
-3% -$48.8K 0.12% 104
2022
Q2 		$1.59M Buy
12,072
+49
+0.4% +$6.43K 0.14% 89
2022
Q1 		$1.59M Buy
12,023
+581
+5% +$69.7K 0.12% 94
2021
Q4 		$1.33M Buy
11,442
+597
+6% +$70.2K 0.1% 130
2021
Q3 		$1.3M Buy
10,845
+498
+5% +$58K 0.11% 117
2021
Q2 		$1.24M Buy
10,347
+456
+5% +$50K 0.11% 134
2021
Q1 		$984K Buy
9,891
+5,035
+104% +$506K 0.09% 153
2020
Q4 		$485K Sell
4,856
-2,021
-29% -$214K 0.05% 221
2020
Q3 		$753K Buy
6,877
+48
+0.7% +$5.34K 0.09% 155
2020
Q2 		$722K Buy
+6,829
New +$705K 0.1% 132
2019
Q1 		– Sell
-4,237
Closed -$325K – 244
2018
Q4 		$325K Buy
+4,237
New +$331K 0.05% 193

Other funds holding AZN

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
CAM
Cidel Asset Management Toronto, Ontario, Ontario, Canada $2.08B AUM 24.89% 1-Year Est. Return
MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
SAM
Sycomore Asset Management Paris, France $932M AUM 51.25% 1-Year Est. Return

Venturi Wealth Management's AZN Position: Q2 2026 in Review

Venturi Wealth Management reduced its AstraZeneca (AZN) stake by 3.9% in Q2 2026, selling an estimated $108K and leaving 14,174 shares worth $2.69M. The position accounts for 0.1% of the portfolio, ranked #102.

Venturi Wealth Management first reported a position in AZN in Q4 2018 and has held it in 26 quarters since. The position peaked at $2.91M in Q1 2026. 351 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Venturi Wealth Management held 14,174 shares of AstraZeneca worth $2.69M as of Q2 2026.
  • Venturi Wealth Management sold 576 AstraZeneca shares in Q2 2026, an estimated $108K.
  • AstraZeneca made up 0.1% of Venturi Wealth Management's portfolio in Q2 2026, its #102 holding.
  • Venturi Wealth Management first reported a position in AstraZeneca in Q4 2018 and has held it in 26 quarters since.
  • Venturi Wealth Management's AstraZeneca position peaked at $2.91M in Q1 2026.
  • 351 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Venturi Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.